Lazard Asset Management LLC Kura Oncology, Inc. Transaction History
Lazard Asset Management LLC
- $70 Billion
- Q3 2025
A detailed history of Lazard Asset Management LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 10,423 shares of KURA stock, worth $116,737. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,423
Previous 3,234
222.29%
Holding current value
$116,737
Previous $18,000
411.11%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding KURA
# of Institutions
214Shares Held
81.2MCall Options Held
900KPut Options Held
228K-
Bvf Inc San Francisco, CA8.62MShares$96.5 Million4.13% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.12MShares$90.9 Million2.16% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$78 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.47MShares$61.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.67MShares$52.3 Million0.64% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $749M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...